Skip to main content

Table 2 Accuracy of detecting CIN2+ for different sampling media in combination with three HPV testing methods

From: Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening

Methods

Sampling Medium

HPV Prevalence

Accuracy

(%)

Sensitivity

Specificity

Positive Predictive Value

Negative Predictive Value

 

% (n/N)

95 % CI

% (n/N)

95 % CI

% (n/N)

95 % CI

% (n/N)

95 % CI

HC2

FTA

22.8

91.7 (11/12)

76.1 ~ 100.0

79.5 (283/356)

75.3 ~ 83.7

13.1 (11/84)

5.9 ~ 20.3

99.6 (283/284)

98.9 ~ 100.0

Liquid

30.4

91.7 (11/12)

76.1 ~ 100.0

71.6 (255/356)

66.9 ~ 76.3

9.8 (11/112)

4.3 ~ 15.3

99.6 (255/256)

98.8 ~ 100.0

careHPV™

FTA

23.9

83.3 (10/12)

62.2 ~ 100.0

78.1 (278/356)

73.8 ~ 82.4

11.4 (10/88)

4.8 ~ 18

99.3 (278/280)

98.3 ~ 100.0

Liquid

28.8

83.3 (10/12)

62.2 ~ 100.0

73.0 (260/356)

68.4 ~ 77.6

9.4 (10/106)

3.8 ~ 15

99.2 (260/262)

98.1 ~ 100.0

Cobas®4800

FTA

39.4

91.7 (11/12)

76.1 ~ 100.0

62.4 (222/356)

57.4 ~ 67.4

7.6 (11/145)

3.3 ~ 11.9

99.6 (222/223)

98.8 ~ 100.0

Liquid

32.1

91.7 (11/12)

76.1 ~ 100.0

69.9 (249/356)

65.1 ~ 74.7

9.3 (11/118)

4.1 ~ 14.5

99.6 (249/250)

98.8 ~ 100.0

  1. 95 % CI 95 % confidence interval, FTA Whatman Indicating FTA Elute® card, HC2 Hybrid capture 2